self-amplifying RNA vaccine (VLP Therapeutics Japan/Denka/BIKEN Foundation)

N/A

Report date: 2026/01/26 17:59:17

Base Information

Drug Nameself-amplifying RNA vaccine (VLP Therapeutics Japan/Denka/BIKEN Foundation)
Drug Alias NameRNA vaccine (VLP Therapeutics Japan/Denka/BIKEN Foundation)self-amplifying RNA (replicon) influenza vaccine (VLP Therapeutics Japan/Denka/BIKEN Foundation)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVlp Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesBIKEN FoundationVlp TherapeuticsDenka Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A